iconiifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Ajooni Biotech successfully develops Lumpy Skin Disease Medicine for Cattle

8 Sept 2022 , 01:24 PM

Ajooni Biotech Ltd has successfully developed lumpy skin disease medicine for Cattle.

According to the regulatory filing, the company is constantly experimenting and working on research-based different health care solutions by a strong Research & Development team, working closely with leading research agencies, universities and independent scientists for product and process development.

"Its focus is to develop cost effective solutions to improve animal health, sustainable productivity of dairy and poultry farm, and thereby, the profitability of farmers", the company said on Thursday.

Further, the recent fast-spreading outbreak of lumpy skin disease (LSD) in cattle is estimated to have infected large number of animals particularly cows across India and over thousands of head of cattle have succumbed to the disease.

The Company has been working for the last few months to develop new medicines to control Lumpy Skin disease as a part of its regular research work and has been successful to produce a most effective formula at very reasonable cost by our expert team of Doctors and Scientists.

The animal starts improving with first few doses and fully recovered with in a week’s time. Ajooni has run very successful trails in Dairy Farms and results are very encouraging and really marvelous. The unique product is antipyretic, anti-inflammatory and antiallergic also. It overcomes the ill effects of Lumpy skin disease in addition to fever, lacrimation, hyper salivation and characteristic skin eruption.

In addition to this, Ajooni has an agreement with IFFCO KISAN, an organization committed to enriching farmer life and a sustainable ecosystem had started showing results with their combined efforts of marketing and supply of BIS Mark Cattle Feed for the state of Punjab, Haryana, Rajasthan, Himachal Pradesh, Jammu & Kashmir, and Western UP.

The Company has a long-term business plan to expand its facilities to produce Camel feed, Poultry feed, Aqua feed, Horse feed, and Sheep/Goat feed. The Company has set up under the project titled "Dairy Value Chain Development in Bundelkhand region of Uttar Pradesh" financially supported by National Rural Livelihood Mission (NRLM) & Uttar Pradesh State Rural Livelihood Mission (UP-SRLM) with NDDB Dairy Services (NDS) as technical Support Agency.

At around 1:22 PM, Ajooni Biotech was trading at Rs41.85 per equity share lower by 0.95% on the NSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • agreement
  • Ajooni Biotech
  • Ajooni Biotech Limited
  • Ajooni Biotech Limited announcement
  • Ajooni Biotech Limited markets
  • Ajooni Biotech Limited news
  • Ajooni Biotech Limited NSE
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

4 Mar 2024   |   09:10 AM
4 Mar 2024   |   06:22 PM
4 Mar 2024   |   08:40 AM
4 Mar 2024   |   06:37 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.